Table 2.
Deaths in placebo- and azithromycin-treated clusters due to the top 10 causes using InterVA
| InterVA output cause | Number of deaths in placebo arm (%) | Number of deaths in azithromycin arm (%) | Number of deaths in both arms (%) |
|---|---|---|---|
| Malaria | 256 (42.9) | 245 (45.9) | 501 (44.3) |
| HIV/AIDS-related death | 103 (17.3) | 71 (13.3) | 174 (15.4) |
| Acute respiratory infection, including pneumonia | 94 (15.7) | 77 (14.4) | 171 (15.1) |
| Diarrheal diseases | 48 (8.0) | 45 (8.4) | 93 (8.2) |
| Indeterminate | 19 (3.2) | 15 (2.8) | 34 (3.0) |
| Acute abdomen | 16 (2.7) | 15 (2.8) | 31 (2.7) |
| Meningitis and encephalitis | 10 (1.7) | 16 (3.0) | 26 (2.3) |
| Severe malnutrition | 12 (2.0) | 9 (1.7) | 21 (1.9) |
| Accidental exposure to smoke fire and flame | 7 (1.2) | 6 (1.1) | 13 (1.2) |
| Epilepsy | 2 (0.3) | 9 (1.7) | 11 (1.0) |
| Other | 30 (5.0) | 26 (4.9) | 56 (4.9) |
| Total | 597 (100) | 534 (100) | 1,131 (100) |